These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29438985)

  • 1. Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer.
    Jeitany M; Leroy C; Tosti P; Lafitte M; Le Guet J; Simon V; Bonenfant D; Robert B; Grillet F; Mollevi C; El Messaoudi S; Otandault A; Canterel-Thouennon L; Busson M; Thierry AR; Martineau P; Pannequin J; Roche S; Sirvent A
    EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29438985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DDR1 inhibition as a new therapeutic strategy for colorectal cancer.
    Sirvent A; Lafitte M; Roche S
    Mol Cell Oncol; 2018; 5(4):e1465882. PubMed ID: 30250919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling.
    Frolov A; Evans IM; Li N; Sidlauskas K; Paliashvili K; Lockwood N; Barrett A; Brandner S; Zachary IC; Frankel P
    Sci Rep; 2016 Jun; 6():27378. PubMed ID: 27293031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3.
    Borza CM; Bolas G; Bock F; Zhang X; Akabogu FC; Zhang MZ; de Caestecker M; Yang M; Yang H; Lee E; Gewin L; Fogo AB; McDonald WH; Zent R; Pozzi A
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34941574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
    Day E; Waters B; Spiegel K; Alnadaf T; Manley PW; Buchdunger E; Walker C; Jarai G
    Eur J Pharmacol; 2008 Dec; 599(1-3):44-53. PubMed ID: 18938156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p-mediated DDR1 and JAG1 signalling.
    Chen LY; Zhi Z; Wang L; Zhao YY; Deng M; Liu YH; Qin Y; Tian MM; Liu Y; Shen T; Sun LN; Li JM
    J Pathol; 2019 May; 248(1):103-115. PubMed ID: 30666650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.
    Tao Y; Wang R; Lai Q; Wu M; Wang Y; Jiang X; Zeng L; Zhou S; Li Z; Yang T; Yao Y; Wu Y; Yu L; Fu Y; Lai W; Peng Y; Lu Y; Zhang Z; Guo C; Zhang G; Gou L; Yang J
    Mol Oncol; 2019 Sep; 13(9):1855-1873. PubMed ID: 31116512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
    Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
    Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
    Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
    Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Vascular Calcification Mediated by the Collagen Receptor Discoidin Domain Receptor 1 via the Phosphoinositide 3-Kinase/Akt/Runt-Related Transcription Factor 2 Signaling Axis.
    Lino M; Wan MH; Rocca AS; Ngai D; Shobeiri N; Hou G; Ge C; Franceschi RT; Bendeck MP
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1878-1889. PubMed ID: 29930002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of DDR1 reduces invasive features of human A375 melanoma, HT29 colon carcinoma and SK-HEP hepatoma cells.
    Romayor I; Badiola I; Olaso E
    Cell Adh Migr; 2020 Dec; 14(1):69-81. PubMed ID: 32090682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nilotinib, a Discoidin domain receptor 1 (DDR1) inhibitor, induces apoptosis and inhibits migration in breast cancer.
    Wang S; Xie Y; Bao A; Li J; Ye T; Yang C; Yu S
    Neoplasma; 2021 Sep; 68(5):975-982. PubMed ID: 34263649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors.
    Dong R; Zhou X; Wang M; Li W; Zhang JY; Zheng X; Tang KX; Sun LP
    Bioorg Med Chem; 2021 Jan; 29():115876. PubMed ID: 33246255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1.
    Huang H; Svoboda RA; Lazenby AJ; Saowapa J; Chaika N; Ding K; Wheelock MJ; Johnson KR
    J Biol Chem; 2016 Oct; 291(44):23208-23223. PubMed ID: 27605668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer's disease.
    Stevenson M; Varghese R; Hebron ML; Liu X; Ratliff N; Smith A; Turner RS; Moussa C
    J Neuroinflammation; 2023 May; 20(1):116. PubMed ID: 37194065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discoidin Domain Receptor 1 (DDR1) Is Necessary for Tissue Homeostasis in Pancreatic Injury and Pathogenesis of Pancreatic Ductal Adenocarcinoma.
    Ruggeri JM; Franco-Barraza J; Sohail A; Zhang Y; Long D; Pasca di Magliano M; Cukierman E; Fridman R; Crawford HC
    Am J Pathol; 2020 Aug; 190(8):1735-1751. PubMed ID: 32339496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling by discoidin domain receptor 1 in cancer metastasis.
    Gadiya M; Chakraborty G
    Cell Adh Migr; 2018; 12(4):315-323. PubMed ID: 30187813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets.
    Rix U; Hantschel O; Dürnberger G; Remsing Rix LL; Planyavsky M; Fernbach NV; Kaupe I; Bennett KL; Valent P; Colinge J; Köcher T; Superti-Furga G
    Blood; 2007 Dec; 110(12):4055-63. PubMed ID: 17720881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcr is a negative regulator of the Wnt signalling pathway.
    Ress A; Moelling K
    EMBO Rep; 2005 Nov; 6(11):1095-100. PubMed ID: 16211085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma.
    Gupta K; Jones JC; Farias VA; Mackeyev Y; Singh PK; Quiñones-Hinojosa A; Krishnan S
    Front Oncol; 2022; 12():840241. PubMed ID: 35664781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.